October 29th, 2026
Category: Economic and Financial News
July 30th, 2026
Faes Farma increases its revenue by 27% and posts a net profit of 57 million in the first half of the year, reaffirming its guidance for 2026
July 1st, 2026
Faes Farma advances its international expansion through an agreement to commercialise a new urology treatment in Latin America
June 25th, 2026
Faes Farma holds its Annual General Shareholders’ Meeting following a key year in the execution of its Strategic Plan
April 30th, 2026
Faes Farma exceeds €200 million in revenue (+31%) and increases its net profit by +9% in the first quarter
February 26th, 2026
Faes Farma increases its revenue by 23% to €627 million
November 4th, 2025
Faes Farma increases its revenue by more than 15% to €454 million
September 2nd, 2025
Faes Farma completes the acquisition of SIFI and consolidates its international leadership in ophthalmology
July 24th, 2025
Faes Farma increases revenue by 12.3% to €307.4 million
July 16th, 2025
Faes Farma’s Shareholders’ Meeting approves the acquisition of 100% of SIFI
June 25th, 2025
Faes Farma reaffirms its ambition and strategic plan to 2030 to its shareholders
June 10th, 2025